注意力不足過動症的診斷
文獻來源

↑  National Collaborating Centre for Mental Health. . . NICE Clinical Guidelines 72. Leicester: British Psychological Society. 2009: 18–26, 38. ISBN 978-1-85433-471-8. （原始内容存档于2016-01-13） –NCBI Bookshelf.
↑  Dulcan, Mina K.; Lake, MaryBeth. .  4th illustrated. American Psychiatric Publishing. 2011: 34. ISBN 978-1-58562-416-4 –Google Books.
↑  Mayes R, Bagwell C, Erkulwater JL.  illustrated. Harvard University Press. 2009: 4–24. ISBN 978-0-674-03163-0.
↑  National Collaborating Centre for Mental Health. . . NICE Clinical Guidelines 72. Leicester: British Psychological Society. 2009: 116–7, 119. ISBN 978-1-85433-471-8. （原始内容存档于2016-01-13） –NCBI Bookshelf.
↑  . August 2002. （原始内容存档于2010-05-01）.
↑  Sand T, Breivik N, Herigstad A. . Tidsskrift for Den Norske Laegeforening. February 2013, 133 (3): 312–6. PMID 23381169. doi:10.4045/tidsskr.12.0224 （挪威语）.
↑  Millichap JG, Millichap JJ, Stack CV. . Clinical EEG and Neuroscience. July 2011, 42 (3): 180–4. PMID 21870470. doi:10.1177/155005941104200307.
1 2  American Psychiatric Association. . American Psychiatric Association. 2000. ISBN 978-0-89042-025-6. （原始内容存档于2016-05-12）.
↑  . MedlinePlus. 2018-07-09  [2018-07-15]. （原始内容存档于2017-07-15）. Hyperactivity is often considered more of a problem for schools and parents than it is for the child. But many hyperactive children are unhappy, or even depressed. Hyperactive behavior may make a child a target for bullying, or make it harder to connect with other children. Schoolwork may be more difficult. Kids who are hyperactive are frequently punished for their behavior. Excessive movement (hyperkinetic behavior) often decreases as the child grows older. It may disappear entirely by adolescence.
↑  CDC. . Centers for Disease Control and Prevention. 2017-08-31  [2018-07-15]. （原始内容存档于2014-11-07）. Deciding if a child has ADHD is a several-step process. This page gives you an overview of how ADHD is diagnosed. There is no single test to diagnose ADHD, and many other problems, like sleep disorders, anxiety, depression, and certain types of learning disabilities, can have similar symptoms.
↑  Caroline, SC (编). . Springer Science & Business Media. 2010: 133. ISBN 9780387717982. （原始内容存档于2016-05-06）.
1 2  Kooij, SJ; Bejerot, S; Blackwell, A; Caci, H;  et al. . BMC Psychiatry. 2010, 10: 67. PMC 2942810 . PMID 20815868. doi:10.1186/1471-244X-10-67.
↑  Wiener JM, Dulcan MK.  illustrated. American Psychiatric Publishing. 2004  [2014-11-02]. ISBN 978-1-58562-057-9. （原始内容存档于2016-05-06）.
↑  National Collaborating Centre for Mental Health. . NICE Clinical Guidelines 72. Leicester: British Psychological Society. 2009. ISBN 978-1-85433-471-8. （原始内容存档于2016-01-13） –NCBI Bookshelf.
↑  Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S. . Pediatrics. November 2011, 128 (5): 1007–22. PMC 4500647 . PMID 22003063. doi:10.1542/peds.2011-2654.
↑  Smith BJ, Barkley RA, Shapiro CJ. . Mash EJ, Barkley RA  (编).  4th. New York, NY: Guilford Press. 2007: 53–131. ISBN 978-1-59385-493-5.
1 2 3  . NIMH.   [2018-07-13]. （原始内容存档于2018-06-01）. A person must have at least five symptoms of either inattention and/or hyperactivity-impulsivity.
The symptoms must be present in two or more settings, such as at home and at work. There must be evidence that the symptoms interfere with the person's functioning in these settings.
1 2 3  . Arlington, VA Washington, D.C: American Psychiatric Association,American Psychiatric Association. 2013. ISBN 0-89042-555-8. OCLC 830807378.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24  CDC. . Centers for Disease Control and Prevention. 2017-08-31  [2018-07-15]. （原始内容存档于2014-11-07）.
↑  CDC. . Centers for Disease Control and Prevention. 2017-08-31  [2018-07-15]. （原始内容存档于2014-11-07）.
1 2  高淑芬. . 台北: 心靈工坊. 2016-05-09  [2016-12-12]. ISBN 9789863570592 （中文（臺灣））.
↑  . CHADD.   [2017-11-22]. （原始内容存档于2017-07-23）.
↑  . WebMD. 2017-10-24  [2017-11-22]. （原始内容存档于2017-09-02）.
↑  Barrow, Karen. . ADDitude. 2014-01-14  [2017-11-22]. （原始内容存档于2017-11-27）.
1 2 3 4 5 6 7 8   10. World Health Organization. 2010. （原始内容存档于2014-11-02）.
↑   11 Beta Draft. World Health Organization. （原始内容存档于2017-02-02）.
↑  WHO team for classifications, terminologies and standards/IER.  (PDF). 2015-05-12  [2018-06-01]. （原始内容存档 (PDF)于2017-07-15）.
↑  Adler, Lenard; Kessler, Ronald C; Spencer, Thomas,  (PDF), Gau, Susan Shur-Fen  (编),  (PDF), V1.1, Harvard Medical School, New York University Medical School.: World Health Organization, 2005  [2018-09-22], （原始内容 (PDF)存档于2017-04-06）
↑  Margaret H. Sibley, James M. Swanson, L. Eugene Arnold, Lily T. Hechtman, Elizabeth B. Owens, Annamarie Stehli, Howard Abikoff, Stephen P. Hinshaw, Brooke S. G. Molina, John T. Mitchell, Peter S. Jensen, Andrea L. Howard, Kimberley D. Lakes & William E. Pelham. . Journal of child psychology and psychiatry, and allied disciplines. 2016-09. PMID 27642116. doi:10.1111/jcpp.12620. CONCLUSION:The interview format optimizes young adult self-reporting when parent reports are not available. However, the combination of parent and self-reports from rating scales, using an 'or' rule and a NB threshold optimized the balance between sensitivity and specificity. With this definition, 60% of the ADHD group demonstrated symptom persistence and 41% met both symptom and impairment criteria in adulthood.
↑  CDC. . Centers for Disease Control and Prevention. 2017-08-31  [2018-07-15]. （原始内容存档于2014-11-07）. ADHD often lasts into adulthood. To diagnose ADHD in adults and adolescents age 17 or older, only 5 symptoms are needed instead of the 6 needed for younger children. Symptoms might look different at older ages. For example, in adults, hyperactivity may appear as extreme restlessness or wearing others out with their activity.
1 2 3 4  Scassellati C, Bonvicini C, Faraone SV, Gennarelli M. . J. Am. Acad. Child Adolesc. Psychiatry. October 2012, 51 (10): 1003–1019.e20. PMID 23021477. doi:10.1016/j.jaac.2012.08.015.
↑  Berry, MD. . Reviews on Recent Clinical Trials. January 2007, 2 (1): 3–19. PMID 18473983. doi:10.2174/157488707779318107. （原始内容存档于2017-02-01）. Although there is little direct evidence, changes in trace amines, in particular PE, have been identified as a possible factor for the onset of attention deficit/hyperactivity disorder (ADHD). … Further, amphetamines, which have clinical utility in ADHD, are good ligands at trace amine receptors. Of possible relevance in this aspect is modafanil, which has shown beneficial effects in ADHD patients and has been reported to enhance the activity of PE at TAAR1. Conversely, methylphenidate, …showed poor efficacy at the TAAR1 receptor. In this respect it is worth noting that the enhancement of functioning at TAAR1 seen with modafanil was not a result of a direct interaction with TAAR1.
↑  Al Rahbi, HA; Al-Sabri, RM; Chitme, HR. . Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. April 2014, 22 (2): 101–6. PMC 3950532 . PMID 24648820. doi:10.1016/j.jsps.2013.04.001.
↑  . August 2002  [2008-12-09]. （原始内容存档于2010-05-01）.